EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Neumann, Lisa C ^a   Weinhäusel, Andreas ^b   Thomas, Stefanie ^a   Horsthemke, Bernhard ^a   Lohmann, Dietmar R ^a   Zeschnigk, Michael ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b ARC SEIBERSDORF RESEARCH GMBH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; EFS PROTEIN, HUMAN; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BLOOD CELL; BRAIN; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DEATH; DNA METHYLATION; EFS GENE; FEMALE; FETUS; FETUS LIVER; FIBROBLAST CULTURE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY; MALE; MELANOCYTE; METASTASIS; MUSCLE; ORAL BIOPSY; PROGNOSIS; PROMOTER REGION; SPERM; TISSUE SPECIFICITY; TUMOR CLASSIFICATION; UVEA MELANOMA; ANTIBODY SPECIFICITY; BLOOD; CELL CULTURE; DNA SEQUENCE; GENETICS; MELANOMA; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; UVEA TUMOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; BASE SEQUENCE; CELLS, CULTURED; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; ORGAN SPECIFICITY; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; PROGNOSIS; SEQUENCE ANALYSIS, DNA; UVEAL NEOPLASMS;

EID: 80052037258     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-380     Document Type: Article

References (34)

1. Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004, 64:7205-7209. 10.1158/0008-5472.CAN-04-1750, 15492234.
2. Tschentscher F, Hüsing J, Hölter T, Kruse E, Dresen IG, Jöckel KH, Anastassiou G, Schilling H, Bornfeld N, Horsthemke B, Lohmann DR, Zeschnigk M. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res 2003, 63:2578-2584.
3. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jökel KH, Becher R. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996, 347:1222-1225. 10.1016/S0140-6736(96)90736-9, 8622452.
4. Damato B, Duke C, Coupland SE, Hiscott P, Smith PA, Campbell I, Douglas A, Howard P. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology 2007, 114:1925-1931. 10.1016/j.ophtha.2007.06.012, 17719643.
5. Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010, 330:1410-1413. 10.1126/science.1194472, 3087380, 21051595.
6. Chang SH, Worley LA, Onken MD, Harbour JW. Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis. Melanoma Res 2008, 18:191-200. 10.1097/CMR.0b013e3283005270, 18477893.
7. Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, Schlawe K, Chang HD, Bopp T, Schmitt E, Klein-Hessling S, Serfling E, Hamann A, Huehn J. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007, 5:e38. 10.1371/journal.pbio.0050038, 1783672, 17298177.
8. Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 2002, 99:3740-3745. 10.1073/pnas.052410099, 122594, 11891299.
9. Zeschnigk M, Martin M, Betzl G, Kalbe A, Sirsch C, Buiting K, Gross S, Fritzilas E, Frey B, Rahmann S, Horsthemke B. Massive parallel bisulfite sequencing of CG-rich DNA fragments reveals that methylation of many X-chromosomal CpG islands in female blood DNA is incomplete. Hum Mol Genet 2009, 18:1439-1448. 10.1093/hmg/ddp054, 19223391.
10. Greger V, Passarge E, Höping W, Messmer E, Horsthemke B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 1989, 83:155-158. 10.1007/BF00286709, 2550354.
11. Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, Ahmed S, Shu J, Chen X, Waterland RA, Issa JP. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet 2007, 3:2023-2036. 2041996, 17967063.
12. Deb-Rinker P, Ly D, Jezierski A, Sikorska M, Walker PR. Sequential DNA methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during neuronal differentiation. J Biol Chem 2005, 280:6257-6260. 10.1074/jbc.C400479200, 15615706.
13. Illingworth R, Kerr A, Desousa D, Jorgensen H, Ellis P, Stalker J, Jackson D, Clee C, Plumb R, Rogers J, Humphray S, Cox T, Langford C, Bird A. A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol 2008, 6:e22. 10.1371/journal.pbio.0060022, 2214817, 18232738.
14. Straussman R, Nejman D, Roberts D, Steinfeld I, Blum B, Benvenisty N, Simon I, Yakhini Z, Cedar H. Developmental programming of CpG island methylation profiles in the human genome. Nat Struct Mol Biol 2009, 16:564-571. 10.1038/nsmb.1594, 19377480.
15. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W, Berman DM, Jenuwein T, Pruitt K, Sharkis SJ, Watkins DN, Herman JG, Baylin SB. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007, 39:237-242. 10.1038/ng1972, 2744394, 17211412.
16. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M, Young J, Jacobs I, Laird PW. Epigenetic stem cell signature in cancer. Nat Genet 2007, 39:157-158. 10.1038/ng1941, 17200673.
17. Maat W, van der Velden PA, Out-Luiting C, Plug M, Dirks-Mulder A, Jager MJ, Gruis NA. Epigenetic inactivation of RASSF1a in uveal melanoma. Invest Ophthalmol Vis Sci 2007, 48:486-490. 10.1167/iovs.06-0781, 17251440.
18. Merhavi E, Cohen Y, Avraham BC, Frenkel S, Chowers I, Pe'er J, Goldenberg-Cohen N. Promoter methylation status of multiple genes in uveal melanoma. Invest Ophthalmol Vis Sci 2007, 48:4403-4406. 10.1167/iovs.07-0272, 17898258.
19. Moulin AP, Clement G, Bosman FT, Zografos L, Benhattar J. Methylation of CpG island promoters in uveal melanoma. Br J Ophthalmol 2008, 92:281-285. 10.1136/bjo.2007.127035, 18211945.
20. Zeschnigk M, Tschentscher F, Lich C, Brandt B, Horsthemke B, Lohmann DR. Methylation Analysis of Several Tumour Suppressor Genes Shows a Low Frequency of Methylation of CDKN2A and RARB in Uveal Melanomas. Comp Funct Genomics 2003, 4:329-336. 10.1002/cfg.295, 2448448, 18629284.
21. Tschentscher F, Prescher G, Zeschnigk M, Horsthemke B, Lohmann DR. Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet Cytogenet 2000, 122:13-17. 10.1016/S0165-4608(00)00266-1, 11104026.
22. Hu DN, McCormick SA, Ritch R, Pelton-Henrion K. Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes. Invest Ophthalmol Vis Sci 1993, 34:2210-2219.
23. Fischer S, Lüdecke HJ, Wieczorek D, Böhringer S, Gillessen-Kaesbach G, Horsthemke B. Histone acetylation dependent allelic expression imbalance of BAPX1 in patients with the oculo-auriculo-vertebral spectrum. Hum Mol Genet 2006, 15:581-587. 10.1093/hmg/ddi474, 16407370.
24. Zeschnigk M, Lich C, Buiting K, Doerfler W, Horsthemke B. A single-tube PCR test for the diagnosis of Angelman and Prader-Willi syndrome based on allelic methylation differences at the SNRPN locus. Eur J Hum Genet 1997, 5:94-98.
25. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 1991, 19:4008. 10.1093/nar/19.14.4008, 328507, 1861999.
26. Han W, Cauchi S, Herman JG, Spivack SD. DNA methylation mapping by tag-modified bisulfite genomic sequencing. Anal Biochem 2006, 355:50-61. 10.1016/j.ab.2006.05.010, 16797472.
27. Rohde C, Zhang Y, Jurkowski TP, Stamerjohanns H, Reinhardt R, Jeltsch A. Bisulfite sequencing Data Presentation and Compilation (BDPC) web server--a useful tool for DNA methylation analysis. Nucleic Acids Res 2008, 36:e34. 10.1093/nar/gkn083, 2275153, 18296484.
28. Ronan A, Buiting K, Dudding T. Atypical Angelman syndrome with macrocephaly due to a familial imprinting center deletion. Am J Med Genet A 2008, 146A:78-82. 10.1002/ajmg.a.31952, 17975803.
29. Ghosh S, Yates AJ, Fruhwald MC, Miecznikowski JC, Plass C, Smiraglia D. Tissue specific DNA methylation of CpG islands in normal human adult somatic tissues distinguishes neural from non-neural tissues. Epigenetics 2010, 5:527-538. 10.4161/epi.5.6.12228, 20505344.
30. Ishino M, Ohba T, Sasaki H, Sasaki T. Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn. Oncogene 1995, 11:2331-2338.
31. Alexandropoulos K, Baltimore D. Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin. Genes Dev 1996, 10:1341-1355. 10.1101/gad.10.11.1341, 8647432.
32. Tikhmyanova N, Little JL, Golemis EA. CAS proteins in normal and pathological cell growth control. Cell Mol Life Sci 2010, 67:1025-1048. 10.1007/s00018-009-0213-1, 2836406, 19937461.
33. Danzl NM, Donlin LT, Alexandropoulos K. Regulation of medullary thymic epithelial cell differentiation and function by the signaling protein Sin. J Exp Med 2010, 207:999-1013. 10.1084/jem.20092384, 2867288, 20404100.
34. Donlin LT, Danzl NM, Wanjalla C, Alexandropoulos K. Deficiency in expression of the signaling protein Sin/Efs leads to T-lymphocyte activation and mucosal inflammation. Mol Cell Biol 2005, 25:11035-11046. 10.1128/MCB.25.24.11035-11046.2005, 1316950, 16314525.